Finance Home - My Yahoo - Yahoo! - Help

Friday, December 25, 2009, 9:57PM ET - U.S. Markets Closed for Christmas. Dow  0.51% Nasdaq  0.71%

Orexigen Therapeutics, Inc. (OREX)

On Dec 24: 8.31   0.14 (1.66%)

MORE ON OREX

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Wed, Dec 23, 2009 • Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635 PR Newswire (Wed, Dec 23) • On Gaining More Impotence & Weightloss Drugs at CNBC (Wed, Dec 23) Tue, Dec 22, 2009 • [video] Top 2010 Stocks Under $10 at TheStreet.com (Tue, Dec 22) • [video] Top Stocks Under $10 for 2010 at TheStreet.com (Tue, Dec 22) • UPDATE - Arena files for approval for weight loss drug at Reuters (Tue, Dec 22) • Arena files for FDA approval of obesity drug AP (Tue, Dec 22) Fri, Dec 18, 2009 • OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online (Fri, Dec 18) Thu, Dec 10, 2009 • [video] Top 2010 Stocks Under $10 at TheStreet.com (Thu, Dec 10) Sat, Nov 28, 2009 • 12 Years Of Patent Protection For Biologics Based Research And Development Creates Buying Opportunity In Biotech Stocks Wall Street Transcript (Sat, Nov 28) Thu, Nov 26, 2009 • Insider Buying Bodes Well For Orexigen at Seeking Alpha (Thu, Nov 26) Wed, Nov 25, 2009 • Founder Scott Cook Sells $14.7M Worth of Intuit TheStreet.com (Wed, Nov 25) Tue, Nov 24, 2009 • OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E EDGAR Online (Tue, Nov 24) • Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) PR Newswire (Tue, Nov 24) Mon, Nov 23, 2009 • The Side Effect of Developing Obesity Drugs at Motley Fool (Mon, Nov 23) • Poniard Finds Cash to Keep Lights On: BioBuzz at TheStreet.com (Mon, Nov 23) • Cel-Sci Chairman Sells Stock, Despite Sweetheart Loan Deal: BioBuzz at TheStreet.com (Mon, Nov 23) • FDA Issues New Obesity Drug Heart Warning: BioBuzz at TheStreet.com (Mon, Nov 23) • Four Senior Executives Join Orexigen(R) Therapeutics Management Team PR Newswire (Mon, Nov 23) Wed, Nov 18, 2009 • Obesity and ED: Two Big Markets, One Tiny Company at Minyanville.com (Wed, Nov 18) • Obesity and ED: Two Big Markets, One Tiny Company at Minyanville.com (Wed, Nov 18) Older Headlines - Download Recent Headlines View headlines from: Wed, Nov 18, 2009Wed, Nov 11, 2009Wed, Nov 4, 2009Wed, Oct 28, 2009Wed, Oct 21, 2009Wed, Oct 14, 2009Wed, Oct 7, 2009Wed, Sep 30, 2009Wed, Sep 23, 2009Wed, Sep 16, 2009 Add OREX News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage